Ravasio, R., Antonelli, S., Rogai, V., Fakhouri, W., Capron, J.P. and Losi, S. 2018. Mean cost per number needed to treat of baricitinib versus adalimumab in the treatment of rheumatoid arthritis in Italy. Global and Regional Health Technology Assessment. 5, 1 (Jul. 2018). DOI:https://doi.org/10.33393/grhta.2018.435.